Translational Development Acquisition (TDACU) Competitors $10.36 -0.16 (-1.52%) As of 08/11/2025 02:27 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOwnershipSEC FilingsTrendsBuy This Stock TDACU vs. ONCHU, ASPCU, AGBAW, AGNCP, AGNCO, AGNCN, AGNCM, AGNCL, ANSCW, and ANSCUShould you be buying Translational Development Acquisition stock or one of its competitors? The main competitors of Translational Development Acquisition include 1RT Acquisition (ONCHU), A SPAC III Acquisition (ASPCU), AGBA Group (AGBAW), AGNC Investment (AGNCP), AGNC Investment (AGNCO), AGNC Investment (AGNCN), AGNC Investment (AGNCM), AGNC Investment (AGNCL), Agriculture & Natural Solutions Acquisition (ANSCW), and Agriculture & Natural Solutions Acquisition (ANSCU). These companies are all part of the "trading" industry. Translational Development Acquisition vs. Its Competitors 1RT Acquisition A SPAC III Acquisition AGBA Group AGNC Investment AGNC Investment AGNC Investment AGNC Investment AGNC Investment Agriculture & Natural Solutions Acquisition Agriculture & Natural Solutions Acquisition Translational Development Acquisition (NASDAQ:TDACU) and 1RT Acquisition (NASDAQ:ONCHU) are both investment offices industry companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings and profitability. Which has higher valuation & earnings, TDACU or ONCHU? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTranslational Development AcquisitionN/AN/AN/AN/AN/A1RT AcquisitionN/AN/AN/AN/AN/A Is TDACU or ONCHU more profitable? Company Net Margins Return on Equity Return on Assets Translational Development AcquisitionN/A N/A N/A 1RT Acquisition N/A N/A N/A Does the media prefer TDACU or ONCHU? In the previous week, 1RT Acquisition had 1 more articles in the media than Translational Development Acquisition. MarketBeat recorded 2 mentions for 1RT Acquisition and 1 mentions for Translational Development Acquisition. Translational Development Acquisition's average media sentiment score of 1.87 beat 1RT Acquisition's score of 0.93 indicating that Translational Development Acquisition is being referred to more favorably in the media. Company Overall Sentiment Translational Development Acquisition Very Positive 1RT Acquisition Positive SummaryTranslational Development Acquisition and 1RT Acquisition tied by winning 1 of the 2 factors compared between the two stocks. Get Translational Development Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for TDACU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TDACU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TDACU vs. The Competition Export to ExcelMetricTranslational Development AcquisitionInvestment Offices IndustryFinance SectorNASDAQ ExchangeMarket CapN/A$178.85M$12.21B$9.69BDividend YieldN/AN/A5.64%4.14%P/E RatioN/AN/A19.5425.31Price / SalesN/AN/A26.27103.25Price / CashN/A36,784.7921.3258.50Price / BookN/AN/A2.226.01Net IncomeN/A-$160K$1.00B$265.10M7 Day Performance-1.52%0.01%1.41%1.13%1 Month PerformanceN/A-0.33%1.31%2.44%1 Year PerformanceN/A6.75%544.66%27.98% Translational Development Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TDACUTranslational Development AcquisitionN/A$10.36-1.5%N/AN/A$0.00N/A0.00N/APositive NewsONCHU1RT AcquisitionN/A$10.52flatN/AN/A$0.00N/A0.002Negative NewsQuiet Period ExpirationASPCUA SPAC III AcquisitionN/A$10.50+1.3%N/AN/A$0.00N/A0.00N/AGap UpAGBAWAGBA GroupN/A$0.06-0.5%N/A-69.4%$0.00$38.55M0.00152AGNCPAGNC InvestmentN/A$25.23-0.4%N/A+4.7%$0.00$496M0.0050Negative NewsAGNCOAGNC InvestmentN/A$25.52flatN/A+2.8%$0.00$496M0.0050AGNCNAGNC InvestmentN/A$25.71-0.3%N/A+0.4%$0.00$496M0.0050AGNCMAGNC InvestmentN/A$25.130.0%N/A-0.1%$0.00$496M0.0050AGNCLAGNC InvestmentN/A$25.25-0.4%N/A+5.4%$0.00$496M0.0050ANSCWAgriculture & Natural Solutions AcquisitionN/A$0.25+0.1%N/AN/A$0.00N/A0.00N/AGap UpANSCUAgriculture & Natural Solutions AcquisitionN/A$12.27+10.6%N/AN/A$0.00N/A0.00N/AGap Down Related Companies and Tools Related Companies ONCHU Competitors ASPCU Competitors AGBAW Competitors AGNCP Competitors AGNCO Competitors AGNCN Competitors AGNCM Competitors AGNCL Competitors ANSCW Competitors ANSCU Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TDACU) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredElon Musk: “Nothing happens without this…”Lithium has fueled the EV boom, but another resource is even more critical. Without it, over 20 million electr...Behind the Markets | SponsoredSell these stocks now—what to buy insteadSell these stocks now—Here’s what to buy instead Wall Street legend Marc Chaikin says you must know these 3...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredAmericans are rushing into gold (but not billionaires!)Billionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Translational Development Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Translational Development Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access